Literature DB >> 2452184

Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation.

M Brunswick1, F D Finkelman, P F Highet, J K Inman, H M Dintzis, J J Mond.   

Abstract

To investigate the properties which enable type 2 Ag, as exemplified by dextran and Ficoll, to stimulate high levels of antibody responses in the relative absence of T cells, we conjugated anti-IgD and anti-IgM mAb to both dextran and Ficoll and examined their B cell-activating properties. Such conjugated anti-Ig antibodies stimulated both early and later stages of B cell activation at picogram concentrations, which are at least 1000-fold lower than that required for B cell stimulation by unconjugated anti-Ig antibodies, and the level of proliferation they stimulated was on average 10-fold greater. Furthermore, concentrations of anti-Ig dextran (100 pg/ml) which modulated little sIgD from the B cell surface were strong inducers of enhanced B cell expression of MHC class II molecules. Conjugation of Fab fragments of anti-IgD or nonmitogenic anti-IgM mAb to dextran rendered them as mitogenic as dextran conjugated to strongly stimulatory anti-IgD or anti-IgM antibodies. The ability of dextran and Ficoll to serve as effective carrier molecules for anti-IgD was not related solely to their large m.w., because anti-IgD coupled to polymerized BSA (m.w. 1.5 X 10(6), was only 10- to 50-fold more potent than unconjugated anti-IgD antibodies at stimulating B cell DNA synthesis. These results suggest, therefore, that the unique ability of picogram concentrations of haptenated type 2 Ag to stimulate Ig secretion in the absence of T cells may be a function of their ability to promote effective cross-linking without resulting in the modulation of sIg. This would enable such Ag to mediate repetitive B cell signaling, a situation that cannot be achieved by unconjugated anti-Ig antibodies which result in modulation of sIg at their mitogenic concentrations. These compounds therefore may be employed to study B cell activation stimulated by sIg cross-linking at concentrations that may more closely reflect those which are achieved under physiologic conditions by type 2 Ag.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452184

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

Review 2.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

Review 3.  Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

Authors:  John P O'Rourke; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2015-03-29       Impact factor: 7.090

4.  Modulation of B-lymphocyte and NK cell activities by glycoinositolphospholipid purified from Trypanosoma cruzi.

Authors:  L B De Arruda Hinds; L M Previato; J O Previato; Q Vos; J J Mond; L M Peçanha
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion.

Authors:  C M Snapper; F R Rosas; M R Kehry; J J Mond; L M Wetzler
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Labeling primary amine groups in peptides and proteins with N-hydroxysuccinimidyl ester modified Fe3O4@SiO2 nanoparticles containing cleavable disulfide-bond linkers.

Authors:  Ujwal S Patil; Haiou Qu; Daniela Caruntu; Charles J O'Connor; Arjun Sharma; Yang Cai; Matthew A Tarr
Journal:  Bioconjug Chem       Date:  2013-08-28       Impact factor: 4.774

7.  The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain.

Authors:  Swadhinya Arjunaraja; Paola Massari; Lee M Wetzler; Andrew Lees; Jesus Colino; Clifford M Snapper
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

8.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

9.  Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome.

Authors:  H U Simon; G B Mills; S Hashimoto; K A Siminovitch
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses.

Authors:  M Betts; P Beining; M Brunswick; J Inman; R D Angus; T Hoffman; B Golding
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.